Lyell Immunopharma, Inc.

The current price of LYEL is 2.20 USD — it has decreased by 4.35% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lyell Immunopharma, Inc. stocks are traded under the ticker LYEL.

Lyell Immunopharma, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

LYEL stock is 17.64% volatile and has beta coefficient of 3.03. Check out the list of the most volatile stocks — is Lyell Immunopharma, Inc. there?

LYEL earnings for the last quarter are −0.20 USD per share, whereas the estimation was −0.24 USD resulting in a 17.36% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about Lyell Immunopharma, Inc. earnings.

Lyell Immunopharma, Inc. revenue for the last quarter amounts to ‪25.00 K‬ USD despite the estimated figure of ‪6.25 K‬ USD. In the next quarter revenue is expected to reach ‪3.25 K‬ USD.

Yes, you can track Lyell Immunopharma, Inc. financials in yearly and quarterly reports right on TradingView.

LYEL net income for the last quarter is ‪−52.93 M‬ USD, while the quarter before that showed ‪−50.85 M‬ USD of net income which accounts for −4.08% change. Track more Lyell Immunopharma, Inc. financial stats to get the full picture.

No, LYEL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, LYEL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lyell Immunopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.

LYEL reached its all-time high on Sep 7, 2021 with the price of 19.84 USD, and its all-time low was 1.32 USD and was reached on Oct 9, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 26, 2024, the company has 224.00 employees. See our rating of the largest employees — is Lyell Immunopharma, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lyell Immunopharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lyell Immunopharma, Inc. stock shows the sell signal. See more of Lyell Immunopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Lyell Immunopharma, Inc. future price: according to them, LYEL price has a max estimate of 9.00 USD and a min estimate of 6.00 USD. Read a more detailed Lyell Immunopharma, Inc. forecast: see what analysts think of Lyell Immunopharma, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lyell Immunopharma, Inc. EBITDA is ‪−231.00 M‬ USD, and current EBITDA margin is ‪−177.29 K‬%. See more stats in Lyell Immunopharma, Inc. financial statements.